Jack Lin

Stock Analyst at Morgan Stanley

(1.46)

# 3,400

Out of 5,182 analysts

2

Total ratings

50%

Success rate

1.59%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - Specialty & Generic Biotechnology

Stocks Rated by Jack Lin

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	HCM HUTCHMED (China)	Downgrades: Underweight	$18 → $14	$13.59	+1.18%	1	Sep 22, 2025
	ZLAB Zai Lab	Initiates: Overweight	$48	$22.14	+114.54%	1	Dec 14, 2023

HUTCHMED (China)

Sep 22, 2025

Downgrades: Underweight

Price Target: $18 → $14

Current: $13.59

Upside: +1.18%

Zai Lab

Dec 14, 2023

Initiates: Overweight

Price Target: $48

Current: $22.14

Upside: +114.54%